直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Laura P. Masurovsky

Alissa Lipton and Jeffrey Jacobstein on Obviousness-Type Double Patenting

November 10, 2016

By Alissa K. Lipton; Jeffrey M. Jacobstein

Obviousness-type double patenting is a judicially-created doctrine designed to prevent a patent owner from applying for a second patent which isn’t “patentably distinct” from the claims of a first patent. In many cases, obviousness-type double patenting can occur accidentally, and it’s important for patent holders to know how to avoid this complication. In this podcast, Finnegan attorneys Alissa K. Lipton and Jeffrey M. Jacobstein discuss this issue.

Tags

Obviousness (35 USC § 103)

Downloadable Files

  • LiptonJacobsteinObviousnessTypeDoublePatenting

Related Practices

Patent Drafting and Prosecution

Related Industries

生命科學

製藥

生物技術

Related Offices

Boston, MA

Related Professionals

Alissa K. Lipton
Partner
Washington, DC
+1 202 408 4293
Email
Jeffrey M. Jacobstein
Partner
Boston, MA
+1 617 646 1664
Email

Related Insights

Conference

Patent Litigation Europe 2027

January 18-20, 2027

Amsterdam

Panel Discussion

2026 Advanced Patent Law Institute

December 3-4, 2026

Stanford

Seminar

U.S. Patent Litigation 2026: Key Developments, Strategic Trends, and Winning Before Trial

November 6, 2026

Taipei

Conference

Life Sciences Patent Network North America Fall 2026

November 2-3, 2026

San Francisco

Conference

4th Global Patent Litigation FORUM

October 29, 2026

Munich

Hybrid Conference

2026 Patent Law Institute: Critical Issues & Best Practices – New York

October 29, 2026

New York

Federal Circuit IP Blog

Federal Circuit Dismisses Non-Infringement Appeal of Only Certain Patent Claims, Denies Judge Reassignment

October 23, 2026

Conference

2nd Annual Forum on Pharma & Biotech Patent Litigation USA & Canada

October 14-16, 2026

New York

Federal Circuit IP Blog

Federal Circuit Affirms PTAB Obviousness Finding in DRAM Data Path Patent

October 5, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP